Trademark Details For BIONUTRIX RX (Serial Number 87456496)

  •  Home
  •  Print
BIONUTRIX RX
0
0
0
0
Basic Information
Serial Number  United States - USPTO 87456496
Registration Number 5473329
Mark
BIONUTRIX RX
Filing Date May-19-2017
Status
Registered  
SECTION 8 & .. (702)
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
Attorney Name
TTAB
0
Action Tags
  


  • CHICARELLI, DANA B.

  • Description Of Mark:
  • Color(s) Claimed:
  • Disclaimer:

044Medical, beauty and agricultural

U.S Class(es): 100, 101

Class Status: Active

First Use: Apr-19-2017

First Use in Commerce: Apr-19-2017


11.01.01
11.01.03



Correspondences

NameJoseph E. Maenner
AddressMAENNER & ASSOCIATES, LLC 2723 STOCKLEY LANE DOWNINGTOWN,PA 19335

Prosecution History

  
USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
May-24-2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
May-25-2017NOTICE OF DESIGN SEARCH CODE E-MAILED   MDSCE
Aug-19-2017ASSIGNED TO EXAMINER   DOCKD
Sep-05-2017
NON-FINAL ACTION WRITTEN
  
CNRTR
Sep-05-2017NON-FINAL ACTION E-MAILED   GNRTF
Sep-05-2017
NOTIFICATION OF NON-FINAL ACTION E-MAILED
  
GNRNO
Jan-22-2018EXAMINERS AMENDMENT -WRITTEN   CNEAR
Jan-22-2018EXAMINERS AMENDMENT E-MAILED   GNEAO
Jan-22-2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED   GNENO
Jan-22-2018EXAMINER'S AMENDMENT ENTERED   XAECI
Jan-23-2018APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Feb-14-2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Mar-06-2018PUBLISHED FOR OPPOSITION   PUBOA
Mar-06-2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Apr-23-2018ASSIGNED TO EXAMINER   DOCKD
May-22-2018REGISTERED-PRINCIPAL REGISTER   R.PRA
May-22-2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED   REM1E
May-24-2023TEAS SECTION 8 & 15 RECEIVED   E815I
Nov-22-2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Nov-22-2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.   C15AO
Nov-22-2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED   NA85E